Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Biogen Announced Interim 6-month Biomarker Data From Respond Study Of Spinraza In Infants And Toddlers With Spinal Muscular Atrophy After Zolgensma Treatment, Data Shows That Plasma Neurofilament Light Chain Were Reduced In Nearly All Study Participants

Author: Benzinga Newsdesk | March 06, 2024 08:42am

Posted In: BIIB IONS